AIG Study proves Corbevax booster in individuals vaccinated with COVISHEILD gives maximum protection against Omicron variants
Press Releases (Corbevax)
-
-
CORBEVAX approved as India’s first heterologous COVID-19 booster shot for 18 years and above
-
CORBEVAX gets DCGI Nod as a Heterologous COVID-19 Booster Dose
-
Biological E. Limited reduces CORBEVAX(R) price to Rs.250 a dose
-
Corbevax receives EUA for 12-18 age group
-
CORBEVAXTM gets Drugs Controller General of India approval
